New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
BACKGROUND: Bullous pemphigoid (BP), the most common autoimmune blistering disease, may be diagnostically challenging. Direct immunofluorescence (DIF), indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), and recently, C3d immunohistochemistry (IHC), are used as adjuncts to diagnosis.OBJECTIVE: To compare C3d IHC to DIF, IIF, and ELISA testing in BP diagnosis.METHODS: C3d IHC was performed on skin biopsies from a total of 51 patients (27 BP patients and 24 patients with other blistering diseases) and compared to DIF and IIF, using anti-BP180 or anti-BP230 ELISA results as the gold standard.RESULTS: We found C3d IHC, DIF and IIF had similar sensitivity (74.1%, 63.1%, 70.4%), specificity (95.8%, 100%, 100%), positive predictive value (95.2%, 100%, 100%), and negative predictive value (76.7%, 70.6%, 75%) for BP. Cases with positive C3d IHC, DIF and IIF had significantly higher anti-BP180 and anti-BP230 by ELISA than cases with negative testing (p<0.0001). False-negative IIF was associated with lower BP230 compared to true-positives (p=0.03).LIMITATIONS: This was a single-center, retrospective study.CONCLUSION: Our study compared C3d IHC to DIF and IIF in BP diagnosis, demonstrating C3d IHC on fixed tissue provides similar diagnostic utility to immunofluorescence and ELISA.
View details for DOI 10.1016/j.jaad.2020.02.020
View details for PubMedID 32068042